Breaking the epithelial polarity barrier in cancer: The strange case of LKB1/PAR-4

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1629, 2013, Pages

  Partanen, Johanna I ^a   Tervonen, Topi A ^a   Klefström, Juha ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Basement membrane; Cancer; Cell polarity; Hepsin; LKB1; PAR 4

Indexed keywords

CANCER; CELL ORGANELLE; EMBRYO; ENZYME; GENE; INVERTEBRATE; PROTEIN;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, HUMAN; HEPSIN;

BIOLOGICAL MODEL; CELL POLARITY; EPITHELIUM CELL; HUMAN; METABOLISM; MORPHOGENESIS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; BASEMENT MEMBRANE; LKB1; PAR-4; REVIEW;

AMP-ACTIVATED PROTEIN KINASES; CELL POLARITY; EPITHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; MORPHOGENESIS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES;

BASEMENT MEMBRANE; CANCER; CELL POLARITY; HEPSIN; LKB1; PAR-4;

EID: 84884479862     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0111     Document Type: Review

References (120)

1. Bryant DM, Mostov KE. 2008 From cells to organs: building polarized tissue. Nat. Rev. Mol. Cell Biol. 9, 887-901. (doi:10.1038/nrm2523)
2. Kalluri R. 2003 Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433. (doi:10.1038/nrc1094)
3. Yurchenco PD. 2011 Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb. Perspect. Biol. 3, 1-27. (doi:10.1101/cshperspect. a004911)
4. Durgan J, Kaji N, Jin D, Hall A. 2011 Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis. J. Biol. Chem. 286, 12 461-12 474. (doi:10.1074/jbc.M110.174235)
5. Hao Y, Du Q, Chen X, Zheng Z, Balsbaugh JL, Maitra S, Shabanowitz J, Hunt DF, Macara IG. 2010 Par3 controls epithelial spindle orientation by aPKC-mediated phosphorylation of apical Pins. Curr. Biol. 20, 1809-1818. (doi:10.1016/j.cub.2010.09.032)
6. Lu MS, Johnston CA. 2013 Molecular pathways regulating mitotic spindle orientation in animal cells. Development 140, 1843-1856. (doi:10.1242/ dev.087627)
7. Martin-Belmonte F, Mostov K. 2008 Regulation of cell polarity during epithelial morphogenesis. Curr. Opin. Cell Biol. 20, 227-234. (doi:10.1016/j.ceb. 2008.01.001)
8. Gassama-Diagne A, Yu W, ter Beest M, Martin-Belmonte F, Kierbel A, Engel J, Mostov K. 2006 Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat. Cell Biol. 8, 963-970. (doi:10.1038/ncb1461)
9. Tervonen TA et al. 2011 Faulty epithelial polarity genes and cancer. Adv. Cancer Res. 111, 97-161. (doi:10.1016/B978-0-12-385524-4.00003-9)
10. Runswick SK, O'Hare MJ, Jones L, Streuli CH, Garrod DR. 2001 Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat. Cell Biol. 3, 823-830. (doi:10.1038/ncb0901-823)
11. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ. 2002 β4 integrin-dependent formation of polarized threedimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell. 2, 205-216. (doi:10.1016/ S1535-6108(02)00125-3)
12. Yu W, Datta A, Leroy P, O'Brien LE, Mak G, Jou TS, Matlin KS, Mostov KE, Zegers MM. 2005 β1-integrin orients epithelial polarity via Rac1 and laminin. Mol. Biol. Cell 16, 433-445. (doi:10.1091/mbc.E04-05-0435)
13. Orlando K, Guo W. 2009 Membrane organization and dynamics in cell polarity. Cold Spring Harb. Perspect. Biol. 1, a001321. (doi:10.1101/ cshperspect.a001321)
14. Mellman I, Nelson WJ. 2008 Coordinated protein sorting, targeting and distribution in polarized cells. Nat. Rev. Mol. Cell Biol. 9, 833-845. (doi:10.1038/ nrm2525)
15. Aumailley M, Pesch M, Tunggal L, Gaill F, Fassler R. 2000 Altered synthesis of laminin 1 and absence of basement membrane component deposition in (beta)1 integrin-deficient embryoid bodies. J. Cell Sci. 113, 259-268.
16. Bilder D. 2004 Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev. 18, 1909-1925. (doi:10.1101/gad.1211604)
17. Goldstein B, Macara IG. 2007 The PAR proteins: fundamental players in animal cell polarization. Dev. Cell 13, 609-622. (doi:10.1016/j.devcel. 2007.10.007)
18. Polyak K. 2010 Molecular markers for the diagnosis and management of ductal carcinoma in situ. J. Natl Cancer Inst. Monogr. 2010, 210-213. (doi:10.1093/jncimonographs/lgq019)
19. Canel M, Serrels A, Frame MC, Brunton VG. 2013 E-cadherin-integrin crosstalk in cancer invasion and metastasis. J. Cell Sci. 126, 393-401. (doi:10.1242/ jcs.100115)
20. Scheel C, Weinberg RA. 2012 Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396-403. (doi:10.1016/j.semcancer.2012.04.001)
21. Partanen JI, Nieminen AI, Klefstrom J. 2009 3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc. Cell Cycle 8, 716-724. (doi:10.4161/cc.8.5.7786)
22. Humbert PO, Dow LE, Russell SM. 2006 The Scribble and Par complexes in polarity and migration: friends or foes? Trends Cell Biol. 16, 622-630. (doi:10. 1016/j.tcb.2006.10.005)
23. Pease JC, Tirnauer JS. 2011 Mitotic spindle misorientation in cancer: out of alignment and into the fire. J. Cell Sci. 124, 1007-1016. (doi:10.1242/jcs.081406)
24. Muschler J, Streuli CH. 2010 Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb. Perspect. Biol. 2, a003202. (doi:10.1101/cshperspect.a003202)
25. Egeblad M, Nakasone ES, Werb Z. 2010 Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884-901. (doi:10.1016/j.devcel.2010.05.012)
26. Brumby AM, Richardson HE. 2003 Scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J. 22, 5769-5779. (doi:10.1093/emboj/cdg548)
27. Pagliarini RA, Xu T. 2003 A genetic screen in Drosophila for metastatic behavior. Science 302, 1227-1231. (doi:10.1126/science.1088474)
28. Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey-Harroche D. 2008 Polarity complex proteins. Biochim. Biophys. Acta 1778, 614-630. (doi:10.1016/j.bbamem.2007.08.029)
29. Rothenberg SM et al. 2010 A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res. 70, 2158-2164. (doi:10.1158/0008-5472.CAN-09-3458)
30. Banks L, Pim D, Thomas M. 2012 Human tumour viruses and the deregulation of cell polarity in cancer. Nat. Rev. Cancer 12, 877-886. (doi:10.1038/nrc3400)
31. Leung CT, Brugge JS. 2012 Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature 482, 410-413. (doi:10.1038/nature10826)
32. Partanen JI et al. 2012 Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity. Proc. Natl Acad. Sci. USA 109, E388-E397. (doi:10.1073/pnas.1120421109)
33. Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK. 2008 Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135, 865-878. (doi:10.1016/j.cell. 2008.09.045)
34. McCaffrey LM, Montalbano J, Mihai C, Macara IG. 2012 Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 22, 601-614. (doi:10.1016/j.ccr.2012.10.003)
35. Lee M, Vasioukhin V. 2008 Cell polarity and cancer: cell and tissue polarity as a non-canonical tumor suppressor. J. Cell Sci. 121, 1141-1150. (doi:10.1242/jcs.016634)
36. Huang L, Muthuswamy SK. 2010 Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators. Curr. Opin. Genet. Dev. 20, 41-50. (doi:10.1016/j.gde.2009.12.001)
37. Hardie DG, Alessi DR. 2013 LKB1 and AMPK and the cancer-metabolism link-ten years after. BMC Biol. 11, 36. (doi:10.1186/1741-7007-11-36)
38. Shaw RJ. 2009 LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. 196, 65-80. (doi:10.1111/j.1748-1716. 2009.01972.x)
39. Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H. 2009 LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol. Rev. 89, 777-798. (doi:10.1152/physrev. 00026.2008)
40. Katajisto P, Vallenius T, Vaahtomeri K, Ekman N, Udd L, Tiainen M, Makela TP. 2007 The LKB1 tumor suppressor kinase in human disease. Biochim. Biophys. Acta 1775, 63-75. (doi:10.1016/j.bbcan. 2006.08.003)
41. Aretz S et al. 2005 High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum. Mutat. 26, 513-519. (doi:10.1002/humu.20253)
42. Hemminki A et al. 1998 A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187. (doi:10.1038/34432)
43. Hearle N et al. 2006 STK11 status and intussusception risk in Peutz-Jeghers syndrome. J. Med. Genet. 43, e41. (doi:10.1136/jmg. 2005.040535)
44. Mehenni H, Resta N, Park JG, Miyaki M, Guanti G, Costanza MC. 2006 Cancer risks in LKB1 germline mutation carriers. Gut 55, 984-990. (doi:10.1136/ gut.2005.082990)
45. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, Krush AJ, Yardley JH, Luk GD. 1987 Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. 316, 1511-1514. (doi:10.1056/NEJM198706113162404)
46. Gill RK et al. 2011 Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene 30, 3784-3791. (doi:10.1038/ onc.2011.98)
47. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG, Sidransky D. 2002 Inactivation of LKB1/ STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62, 3659-3662.
48. Wingo SN et al. 2009 Somatic LKB1 mutations promote cervical cancer progression. PLoS ONE 4, e5137. (doi:10.1371/journal.pone.0005137)
49. Contreras CM et al. 2008 Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res. 68, 759-766. (doi:10.1158/0008-5472. CAN-07-5014)
50. Forster LF, Defres S, Goudie DR, Baty DU, Carey FA. 2000 An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers. J. Clin. Pathol. 53, 791-793. (doi:10.1136/ jcp.53.10.791)
51. Guldberg P, thor Straten P, Ahrenkiel V, Seremet T, Kirkin AF, Zeuthen J. 1999 Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 18, 1777-1780. (doi:10.1038/sj.onc.1202486)
52. Kim CJ et al. 2004 Genetic analysis of the LKB1/ STK11 gene in hepatocellular carcinomas. Eur. J. Cancer 40, 136-141. (doi:10.1016/ S0959-8049(03)00659-2)
53. Su GH et al. 1999 Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol. 154, 1835-1840. (doi:10.1016/S0002-9440(10)65440-5)
54. Fenton H, Carlile B, Montgomery EA, Carraway H, Herman J, Sahin F, Su GH, Argani P. 2006 LKB1 protein expression in human breast cancer. Appl. Immunohistochem. Mol. Morphol. 14, 146-153. (doi:10.1097/01.pai.0000176157.07908.20)
55. Morton JP et al. 2010 LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology 139, e581-e586. (doi:10.1053/j.gastro.2010.04.055)
56. Sahin F, Maitra A, Argani P, Sato N, Maehara N, Montgomery E, Goggins M, Hruban RH, Su GH. 2003 Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod. Pathol. 16, 686-691. (doi:10.1097/01.MP.0000075645.97329.86)
57. Esteller M, Avizienyte E, Corn PG, Lothe RA, Baylin SB, Aaltonen LA, Herman JG. 2000 Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19, 164-168. (doi:10.1038/sj.onc.1203227)
58. Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM. 2002 The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin. Cancer Res. 8, 2085-2090.
59. Zheng B, Jeong JH, Asara JM, Yuan YY, Granter SR, Chin L, Cantley LC. 2009 Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol. Cell 33, 237-247. (doi:10.1016/j.molcel.2008.12.026)
60. Kemphues KJ, Priess JR, Morton DG, Cheng NS. 1988 Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52, 311-320. (doi:10.1016/S0092-8674(88) 80024-2)
61. Hung TJ, Kemphues KJ. 1999 PAR-6 is a conserved PDZ domain-containing protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos. Development 126, 127-135.
62. Martin SG, St Johnston D. 2003 A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 421, 379-384. (doi:10.1038/nature01296)
63. Amin N, Khan A, St Johnston D, Tomlinson I, Martin S, Brenman J, McNeill H. 2009 LKB1 regulates polarity remodeling and adherens junction formation in the Drosophila eye. Proc. Natl Acad. Sci. USA 106, 8941-8946. (doi:10.1073/pnas.0812469106)
64. Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, Peters PJ, Clevers HC. 2004 Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116, 457-466. (doi:10.1016/S0092-8674(04)00114-X)
65. Szczepanska K, Maleszewski M. 2005 LKB1/PAR4 protein is asymmetrically localized in mouse oocytes and associates with meiotic spindle. Gene Expr. Patterns 6, 86-93. (doi:10.1016/j.modgep.2005. 04.013)
66. Barnes AP, Lilley BN, Pan YA, Plummer LJ, Powell AW, Raines AN, Sanes JR, Polleux F. 2007 LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 129, 549-563. (doi:10.1016/j.cell.2007.03.025)
67. Shelly M, Cancedda L, Heilshorn S, Sumbre G, Poo MM. 2007 LKB1/STRAD promotes axon initiation during neuronal polarization. Cell 129, 565-577. (doi:10.1016/j.cell.2007.04.012)
68. Tanwar PS, Kaneko-Tarui T, Zhang L, Teixeira JM. 2012 Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis. Hum. Mol. Genet. 21, 4394-4405. (doi:10.1093/hmg/dds272)
69. Partanen JI, Nieminen AI, Makela TP, Klefstrom J. 2007 Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc. Natl Acad. Sci. USA 104, 14 694-14 699. (doi:10. 1073/pnas.0704677104)
70. Andrew DJ, Ewald AJ. 2010 Morphogenesis of epithelial tubes: insights into tube formation, elongation, and elaboration. Dev. Biol. 341, 34-55. (doi:10.1016/j.ydbio.2009.09.024)
71. Lo B, Strasser G, Sagolla M, Austin CD, Junttila M, Mellman I. 2012 Lkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and-independent pathways. J. Cell. Biol. 199, 1117-1130. (doi:10.1083/jcb.201208080)
72. Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, Morrice NA, Alessi DR, Clevers HC. 2003 Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 22, 3062-3072. (doi:10.1093/emboj/cdg292)
73. Boudeau J, Baas AF, Deak M, Morrice NA, Kieloch A, Schutkowski M, Prescott AR, Clevers HC, Alessi DR. 2003 MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 22, 5102-5114. (doi:10.1093/emboj/cdg490)
74. Dorfman J, Macara IG. 2008 STRADalpha regulates LKB1 localization by blocking access to importinalpha, and by association with Crm1 and exportin-7. Mol. Biol. Cell 19, 1614-1626. (doi:10.1091/mbc. E07-05-0454)
75. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. 2003 Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMPactivated protein kinase cascade. J. Biol. 2, 28. (doi:10.1186/1475-4924-2-28)
76. Lizcano JM et al. 2004 LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23, 833-843. (doi:10.1038/sj.emboj.7600110)
77. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC. 2004 The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl Acad. Sci. USA 101, 3329-3335. (doi:10.1073/pnas.0308061100)
78. Woods A et al. 2003 LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004-2008. (doi:10.1016/j.cub. 2003.10.031)
79. Mirouse V, Swick LL, Kazgan N, St Johnston D, Brenman JE. 2007 LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J. Cell Biol. 177, 387-392. (doi:10.1083/jcb.200702053)
80. Lee JH et al. 2007 Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447, 1017-1020. (doi:10.1038/ nature05828)
81. Zhang L, Li J, Young LH, Caplan MJ. 2006 AMPactivated protein kinase regulates the assembly of epithelial tight junctions. Proc. Natl Acad. Sci. USA 103, 17 272-17 277. (doi:10.1073/pnas. 0608531103)
82. Zheng B, Cantley LC. 2007 Regulation of epithelial tight junction assembly and disassembly by AMPactivated protein kinase. Proc. Natl Acad. Sci. USA 104, 819-822. (doi:10.1073/pnas.0610157104)
83. Morton DG, Shakes DC, Nugent S, Dichoso D, Wang W, Golden A, Kemphues KJ. 2002 The Caenorhabditis elegans par-5 gene encodes a 14-3-3 protein required for cellular asymmetry in the early embryo. Dev. Biol. 241, 47-58. (doi:10.1006/dbio. 2001.0489)
84. Granot Z et al. 2009 LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab. 10, 296-308. (doi:10.1016/j.cmet.2009.08.010)
85. Yamahashi Y, Saito Y, Murata-Kamiya N, Hatakeyama M. 2011 Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization. J. Biol. Chem. 286, 44 576-44 584. (doi:10.1074/jbc.M111.267021)
86. Saadat I et al. 2007 Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447, 330-333. (doi:10.1038/nature05765)
87. Tassan JP, Le Goff X. 2004 An overview of the KIN1/ PAR-1/MARK kinase family. Biol. Cell 96, 193-199. (doi:10.1016/j.biolcel.2003.10.009)
88. Matenia D, Mandelkow EM. 2009 The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem. Sci. 34, 332-342. (doi:10.1016/j.tibs. 2009.03.008)
89. Asada N, Sanada K, Fukada Y. 2007 LKB1 regulates neuronal migration and neuronal differentiation in the developing neocortex through centrosomal positioning. J. Neurosci. 27, 11 769-11 775. (doi:10.1523/JNEUROSCI.1938-07.2007)
90. Valastyan S, Weinberg RA. 2011 Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292. (doi:10.1016/j.cell.2011.09.024)
91. Frantz C, Stewart KM, Weaver VM. 2010 The extracellular matrix at a glance. J. Cell Sci. 123, 4195-4200. (doi:10.1242/jcs.023820)
92. Lu P, Weaver VM, Werb Z. 2012 The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395-406. (doi:10.1083/ jcb.201102147)
93. Levental KR et al. 2009 Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906. (doi:10.1016/j.cell.2009.10.027)
94. Gao Y et al. 2010 LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc. Natl Acad. Sci. USA 107, 18 892-18 897. (doi:10.1073/pnas.1004952107)
95. Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ. 2006 A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 20, 2673-2686. (doi:10.1101/ gad.1451806)
96. Liotta LA, Kleinerman J, Catanzaro P, Rynbrandt D. 1977 Degradation of basement membrane by murine tumor cells. J. Natl Cancer Inst. 58, 1427-1431.
97. Sternlicht MD, Werb Z. 2001 How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516. (doi:10.1146/ annurev.cellbio.17.1.463)
98. Rowe RG, Weiss SJ. 2008 Breaching the basement membrane: who, when and how? Trends Cell Biol. 18, 560-574. (doi:10.1016/j.tcb.2008.08.007)
99. Page-McCaw A, Ewald AJ, Werb Z. 2007 Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233. (doi:10.1038/nrm2125)
100. Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM. 2006 Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol. Cancer Res. 4, 843-849. (doi:10.1158/1541-7786.MCR-06-0118)
101. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. 2001 Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826. (doi:10.1038/35090585)
102. Webb SL, Sanders AJ, Mason MD, Jiang WG. 2011 Type II transmembrane serine protease (TTSP) deregulation in cancer. Front. Biosci. 16, 539-552. (doi:10.2741/3704)
103. Tanimoto H, Yan Y, Clarke J, Korourian S, Shigemasa K, Parmley TH, Parham GP, O'Brien TJ. 1997 Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res. 57, 2884-2887.
104. Miao J, Mu D, Ergel B, Singavarapu R, Duan Z, Powers S, Oliva E, Orsulic S. 2008 Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model. Int. J. Cancer 123, 2041-2047. (doi:10.1002/ijc.23726)
105. Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong HT, Wei XL. 2011 Clinical and biological significance of hepsin overexpression in breast cancer. J. Investig. Med. 59, 803-810. (doi:10.231/JIM.0b013e31821451a1)
106. Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I. 2006 Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr. Relat. Cancer 13, 1109-1120. (doi:10.1677/erc.1.01120)
107. Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V. 2004 Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6, 185-195. (doi:10.1016/j.ccr.2004.07.008)
108. Tripathi M, Nandana S, Yamashita H, Ganesan R, Kirchhofer D, Quaranta V. 2008 Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J. Biol. Chem. 283, 30 576-30 584. (doi:10.1074/jbc.M802312200)
109. Li W et al. 2009 Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis. Cancer Res. 69, 8395-8402. (doi:10.1158/0008-5472.CAN-09-1995)
110. Antalis TM, Buzza MS, Hodge KM, Hooper JD, Netzel-Arnett S. 2010 The cutting edge: membraneanchored serine protease activities in the pericellular microenvironment. Biochem. J. 428, 325-346. (doi:10.1042/BJ20100046)
111. Friis S, Godiksen S, Bornholdt J, Selzer-Plon J, Rasmussen HB, Bugge TH, Lin CY, Vogel LK. 2011 Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase. J. Biol. Chem. 286, 5793-5802. (doi:10.1074/ jbc.M110.186874)
112. Iozzo RV, Sanderson RD. 2011 Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 15, 1013-1031. (doi:10.1111/j.1582-4934.2010.01236.x)
113. Mongiat M, Taylor K, Otto J, Aho S, Uitto J, Whitelock JM, Iozzo RV. 2000 The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275, 7095-7100. (doi:10.1074/jbc.275.10.7095)
114. Iozzo RV, Zoeller JJ, Nystrom A. 2009 Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Mol. Cells 27, 503-513. (doi:10.1007/s10059-009-0069-0)
115. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. 1997 The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22. (doi:10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z)
116. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. 2003 Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925. (doi:10.1038/nrm1261)
117. Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese II DJ. 2010 EGFR signaling in breast cancer: bad to the bone. Semin. Cell Dev. Biol. 21, 951-960. (doi:10.1016/j.semcdb. 2010.08.009)
118. Ganesan R, Kolumam GA, Lin SJ, Xie MH, Santell L, Wu TD, Lazarus RA, Chaudhuri A, Kirchhofer D. 2011 Proteolytic activation of pro-macrophagestimulating protein by hepsin. Mol. Cancer Res. 9, 1175-1186. (doi:10.1158/1541-7786. MCR-11-0004)
119. Welm AL, Sneddon JB, Taylor C, Nuyten DS, van de Vijver MJ, Hasegawa BH, Bishop JM. 2007 The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc. Natl Acad. Sci. USA 104, 7570-7575. (doi:10.1073/pnas. 0702095104)
120. Chen M, Chen LM, Lin CY, Chai KX. 2010 Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor. Mol. Cell Biochem. 337, 259-266. (doi:10.1007/ s11010-009-0307-y)